Switch theme
Sign up to access all valuation multiples
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
2002
38
LTM Revenue $8.7M
Last FY EBITDA -$5.2M
$36.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nuwellis has a last 12-month revenue (LTM) of $8.7M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Nuwellis achieved revenue of $8.7M and an EBITDA of -$5.2M.
Nuwellis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nuwellis valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $8.7M | XXX | $8.7M | XXX | XXX | XXX |
| Gross Profit | $5.7M | XXX | $5.7M | XXX | XXX | XXX |
| Gross Margin | 65% | XXX | 65% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$5.2M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -60% | XXX | XXX | XXX |
| EBIT | -$11.0M | XXX | -$11.0M | XXX | XXX | XXX |
| EBIT Margin | -126% | XXX | -126% | XXX | XXX | XXX |
| Net Profit | -$10.6M | XXX | -$11.2M | XXX | XXX | XXX |
| Net Margin | -122% | XXX | -128% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 15, 2025, Nuwellis's stock price is $233.
Nuwellis has current market cap of $38.5M, and EV of $36.5M.
See Nuwellis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36.5M | $38.5M | XXX | XXX | XXX | XXX | $-353.22 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 15, 2025, Nuwellis has market cap of $38.5M and EV of $36.5M.
Nuwellis's trades at 4.2x EV/Revenue multiple, and -7.0x EV/EBITDA.
Equity research analysts estimate Nuwellis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nuwellis has a P/E ratio of -3.6x.
See valuation multiples for Nuwellis and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $38.5M | XXX | $38.5M | XXX | XXX | XXX |
| EV (current) | $36.5M | XXX | $36.5M | XXX | XXX | XXX |
| EV/Revenue | 4.2x | XXX | 4.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -7.0x | XXX | XXX | XXX |
| EV/EBIT | -3.3x | XXX | -3.3x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.6x | XXX | -3.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -3.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNuwellis's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Nuwellis's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nuwellis's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nuwellis and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -60% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 37% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 191% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nuwellis acquired XXX companies to date.
Last acquisition by Nuwellis was XXXXXXXX, XXXXX XXXXX XXXXXX . Nuwellis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Nuwellis founded? | Nuwellis was founded in 2002. |
| Where is Nuwellis headquartered? | Nuwellis is headquartered in United States of America. |
| How many employees does Nuwellis have? | As of today, Nuwellis has 38 employees. |
| Who is the CEO of Nuwellis? | Nuwellis's CEO is Mr. John L. Erb. |
| Is Nuwellis publicy listed? | Yes, Nuwellis is a public company listed on NAS. |
| What is the stock symbol of Nuwellis? | Nuwellis trades under NUWE ticker. |
| When did Nuwellis go public? | Nuwellis went public in 2012. |
| Who are competitors of Nuwellis? | Similar companies to Nuwellis include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nuwellis? | Nuwellis's current market cap is $38.5M |
| What is the current revenue of Nuwellis? | Nuwellis's last 12 months revenue is $8.7M. |
| What is the current EV/Revenue multiple of Nuwellis? | Current revenue multiple of Nuwellis is 4.2x. |
| Is Nuwellis profitable? | Yes, Nuwellis is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
